Biography for Liz Jones Hollis
Liz Hollis is the editor-at-large in the Life Sciences group at FierceMarkets. Before joining the company, she was the editor of Generic Line at FDAnews, where she also held the position of eZine editor. She also has worked at the Competitive Enterprise Institute as assistant editorial director. She loves the Chicago Bears, running and dogs. She is based at the FierceMarkets main office in Washington, D.C., and can be reached at ehollis@fiercemarkets.com. Follow @FiercePharma on Twitter and find her on LinkedIn.
Articles by Liz Jones Hollis
Abbott down after NIH halts Niaspan study
The NIH has stopped a study with Abbott Laboratories' cholesterol fighter Niaspan 18 months early after results showed the drug failed to prevent heart attacks and even may have boosted stroke risk.
Abbott's White sees bonus, stock awards slip
Abbott Laboratories Chairman and CEO Miles White (photo) received a 2 percent raise last year, to $1.89 million. However, his bonus and other stock awards dipped, according to an SEC filing. White
Cephalon sues to block generic Fentora sales, citing dangers
Fentora maker Cephalon is fighting back against potential generic competition. It has asked a federal judge to block the sale of Watson Pharmaceuticals' generic version of the drug, alleging it is
Herper: Cheap Lipitor could increase health costs
In a report this morning, Forbes' Matthew Herper writes that a war over Lipitor could contribute to higher healthcare premiums--even for those who don't use the drug. As Herper notes, Pfizer late
Pharma firms to create almost 300 jobs in Ireland
Almost 300 new jobs are to be created by three pharmaceutical firms in County Kerry. The 282 new jobs announced by the International Prevention Research Institute, Global Research Services and
Actelion retains help in fight to remove board members
Switzerland's Actelion has hired Goldman Sachs Group and Wachtell, Lipton, Rosen & Katz to help defeat an effort to remove board members, an unnamed source tells Bloomberg. Wachtell is providing
DEA confiscates Georgia's execution drug
The Drug Enforcement Administration has seized Georgia's supply of sodium thiopental, a substance used in lethal injections, amid questions over how it was imported into the state. Sodium thiopental
Daiichi recalling 13 lots of ActHIB vax in Japan
Daiichi Sankyo says it is voluntarily recalling 13 lots of the ActHIB pediatric vaccine after it found an unidentified substance in two syringes. The vaccine is manufactured and marketed by Sanofi
Amgen to buy Pfizer plant in Ireland, saving 280 jobs
Amgen ($AMGN) has agreed to buy a Pfizer manufacturing plant at Dun Laoghaire, County Dublin, securing 280 jobs in the process. The transaction is expected to close in the second quarter of the year.
McNeil Consumer Healthcare reaches consent decree with FDA
After numerous recalls and heated congressional hearings, the FDA is taking action against beleaguered Johnson & Johnson unit McNeil-PPC. The agency announced Thursday it has finalized the terms
